#FirstpostAmerica: The US FDA has approved the nation’s first at-home brain-stimulation device for depression, marking a major shift in mental-health treatment. Developed by Sweden’s Flow Neuroscience, the headset uses transcranial direct current stimulation to target the brain’s mood-regulating region and offers a drug-free alternative for adults with moderate to severe depression. The decision follows clinical trials showing a 58% remission rate after 10 weeks, with a larger 2024 study confirm